Urine and cerebrospinal fluid biomarkers for early glioma detection: a systematic review
Craig Paterson, Jinyue Yu, Philippa Davies, Jack Read, Jennifer C Palmer, Sarah Dawson, Julian PT Higgins, Kathreena M Kurian · 2026
Read Urine and cerebrospinal fluid biomarkers for early glioma detection: a systematic review by Craig Paterson, Jinyue Yu, Philippa Davies, Jack Read, Jennifer C Palmer, Sarah Dawson, Julian PT Higgins, Kathreena M Kurian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13235107.txt.
Description
Craig Paterson and colleagues reviewed in 2026 whether urine or spinal fluid tests could detect glioma brain tumours early. Gliomas cause many years of life lost, and diagnosis today depends on scans and tissue biopsy. Fluid samples could offer a less invasive route, since spinal fluid touches the tumour while urine is easy to collect. Searches of three databases gathered studies testing proteins, metabolites, loose DNA, or small RNA markers.
Twenty studies covering several hundred patients and controls met the review criteria. Most work used spinal fluid, while only five studies tested urine markers. Studies differed too much in markers, methods, and patients for a combined statistical analysis. Small samples and limited study numbers restrict firm conclusions about accuracy. The authors call for larger, well-designed studies before either fluid can support routine early detection.
Catalog record
| CREATOR | Craig Paterson, Jinyue Yu, Philippa Davies, Jack Read, Jennifer C Palmer, Sarah Dawson, Julian PT Higgins, Kathreena M Kurian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |